Global Blood Bag Market was USD XX Million in 2018 and is projected is to exhibit XX% CAGR during the forecast period. The market is projected to be around USD XX Million by 2026. The global blood bag market is marked with growth potential in the coming years. The factors that influence the demand for blood bag market are the growing number of blood donations, along with Blood bags enable better separation of blood components in a more sterile manner and safer transfusion of components.
Wider use of blood component therapy
Increasingly wider use of blood component therapy than whole blood use, thus enabling more effective use of the scarce donor blood that is available. Blood Bags can successfully replace the use of glass bottles for collection storage, transportation and transfusion of blood and blood components since bottles require exhaustive cleaning, rinsing and autoclaving procedures and there are chances of breakage at any stage. Further, use of disposable bags eliminates the possibility of any contamination.
Growing Demand for Transfusion Procedure
Increasing demand for blood-derived products and surge in transfusion procedures are expected to fuel demand for disposable plastic blood bags during the said period. Factors such as increasing incidence of trauma/accidental injuries and tender-based purchases by governments of developing countries coupled with customized blood bags with tracking systems offered by blood bags manufacturers and easy availability of value-added products for blood collection are expected to boost growth of the global disposable plastic blood bags market.
Asia Pacific region holds the highest market of total market share in 2018. The key factors that drive the market include government initiatives and increase in need of blood transfusion in the region. Moreover, prevalence of various diseases, surge in awareness among people, and blood donation campaigns carried out by private and government organizations are anticipated to fuel the demand for disposable blood bags.
Blood Bag Market Segmentation
The global Blood Bag Market is segmented into Bag Types, Application, and by Region. On the basis of the Bag types the market is further bifurcated into collection bags and transfer bags. By Application Types, the market is classified into Hospital based and Standalone. Based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Blood Bag Market Competitive Landscape
The players associated with the global Blood Bag Market are Grifols S.A., Fresenius Se & Co. Kgaa, Hll Lifecare, Ltd., Haemonetics Corporation, Innvol Medical India Ltd., Neomedic Limited, Macopharma Sa, Poly Medicure Ltd., Span Healthcare Private Limited, and Teleflex.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Blood Bag Market, By Application Types
5.1. Blood Bag Market, By Application Types, 2018-2026
5.1.1. Hospital Based
5.1.2. Stand-Alone
Chapter 6. Blood Bag Market, By Bag Types
6.1. Blood Bag Market, By Bag Types, 2018-2026
6.1.1. Collection Bags
6.1.2. Transfer Bags
Chapter 7. Blood Bag Market, By Region
7.1. Blood Bag Market, by Region, 2018-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.2. Rest of North America
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Grifols S.A.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Fresenius Se & Co. Kgaa
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Hll Lifecare, Ltd.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Haemonetics Corporation
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Innvol Medical India Ltd.
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Neomedic Limited
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Macopharma Sa
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Poly Medicure Ltd.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Span Healthcare Private Limited
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. Teleflex
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
© 2019 Data N Analysis. All Rights Reserved | Design by Data N Analysis